U.S. Markets close in 1 hr 6 mins

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.05+0.31 (+1.75%)
As of 2:34PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 327.43
52 Week Low 312.55
50-Day Moving Average 319.02
200-Day Moving Average 319.40

Share Statistics

Avg Vol (3 month) 3148.07k
Avg Vol (10 day) 3210.1k
Shares Outstanding 530.23M
Implied Shares Outstanding 6N/A
Float 12.07M
% Held by Insiders 18.73%
% Held by Institutions 179.61%
Shares Short (Apr 14, 2021) 4768.85k
Short Ratio (Apr 14, 2021) 46.04
Short % of Float (Apr 14, 2021) 49.65%
Short % of Shares Outstanding (Apr 14, 2021) 42.54%
Shares Short (prior month Mar 14, 2021) 4716.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.64%
Return on Equity (ttm)-68.29%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -103.99M
Net Income Avi to Common (ttm)-103.27M
Diluted EPS (ttm)-9.33
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)231.82M
Total Cash Per Share (mrq)7.62
Total Debt (mrq)3.26M
Total Debt/Equity (mrq)1.90
Current Ratio (mrq)12.80
Book Value Per Share (mrq)6.48

Cash Flow Statement

Operating Cash Flow (ttm)-89.08M
Levered Free Cash Flow (ttm)-49.12M